Ghali Mohamed Said, Ali Syed Muhammad, Gibreal Khadija Jaffar Siddig, Singh Rajvir, Shehata Mona S, Al-Zoubi Raed M, Zarour Ahmad
Department of Surgery, Acute Care Surgery, Hamad Medical Corporation, Doha, 3050, Qatar.
Department of General Surgery, Ain Shams University, Cairo, Egypt.
BMC Surg. 2025 Mar 15;25(1):100. doi: 10.1186/s12893-025-02765-4.
Acute cholecystitis (AC) is a prevalent condition in emergency departments (EDs). Standard care involves early laparoscopic cholecystectomy; however, in cases of delayed presentation, high surgical risk, or during situations like the COVID-19 pandemic, percutaneous cholecystostomy (PC) serves as an alternative management strategy. This study reports our center's experience with PC in managing AC, providing insights from a unique geographical context.
We conducted a retrospective review of 97 patients undergoing PC operation from June 1, 2016, to January 1, 2021. The data collected included demographic details, indications for PC, clinical outcomes, ICU admissions, overall mortality, and long-term follow-up.
The cohort comprised 61.9% male patients with a mean age of 67.2 ± 15.5 years. The primary comorbidity was hypertension (83.5%), and 88.6% had an ASA (American Society of Anesthesiologists) score of ≥ III. The main cause of AC was calculous type, and 15.2% of cases were acalculous cholecystitis. Main Tokyo Guidelines 18 (TG 18) grade was grade II and was found in 56.4% of patients. The readmission rate was 33.1% and overall mortality rate was 34% during follow-up. The native population in Qatar were older and burdened with more co-morbidities. High risk of surgery was the main indication for PC, followed by delayed presentation of AC. Patients with delayed presentations were younger (p = 0.051), had higher albumin levels (p = 0.005), and had lower ICU admission rates (p = 0.002) and mortality (p = 0.014) than those with multiple comorbidities. The overall Mortality rates post-PC were 34%, predominantly attributed to underlying conditions rather than the PC procedure itself. Patients who proceeded to post-PC cholecystectomy were younger, had higher albumin levels, and experienced fewer readmissions (p < 0.05).
In high-risk patients or when surgical risk is prohibitive, PC is a viable and effective alternative for AC management. Post-PC cholecystectomy was associated with favorable outcomes, suggesting PC as a bridge to surgery in selected patients. This study highlights the role of PC in a high-risk population within our regional setting.
急性胆囊炎(AC)是急诊科的常见病症。标准治疗方法是早期进行腹腔镜胆囊切除术;然而,对于就诊延迟、手术风险高的情况,或者在像新冠疫情这样的时期,经皮胆囊造瘘术(PC)是一种替代治疗策略。本研究报告了我们中心在使用PC治疗AC方面的经验,从独特的地理背景提供见解。
我们对2016年6月1日至2021年1月1日期间接受PC手术的97例患者进行了回顾性研究。收集的数据包括人口统计学细节、PC的适应证、临床结果、入住重症监护病房情况、总体死亡率以及长期随访情况。
该队列中男性患者占61.9%,平均年龄为67.2±15.5岁。主要合并症为高血压(83.5%),88.6%的患者美国麻醉医师协会(ASA)评分≥III级。AC的主要病因是结石性类型,15.2%的病例为非结石性胆囊炎。主要东京指南18(TG 18)分级为II级,在56.4%的患者中发现。随访期间再入院率为33.1%,总体死亡率为34%。卡塔尔的本地人口年龄较大,合并症较多。手术高风险是PC的主要适应证,其次是AC就诊延迟。就诊延迟的患者比有多种合并症的患者更年轻(p = 0.051),白蛋白水平更高(p = 0.005),入住重症监护病房率更低(p = 0.002),死亡率更低(p = 0.014)。PC术后的总体死亡率为34%,主要归因于基础疾病而非PC手术本身。接受PC术后胆囊切除术的患者更年轻,白蛋白水平更高,再入院次数更少(p < 0.05)。
在高危患者或手术风险过高时,PC是治疗AC的一种可行且有效的替代方法。PC术后胆囊切除术与良好的结果相关,表明PC可作为特定患者手术的桥梁。本研究强调了PC在我们地区高危人群中的作用。